Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Biorepair Plus Parodontogel is a non-fluoride, biomimetic toothpaste and oral care treatment designed specifically for the protection and repair of gingival tissues and tooth enamel. The product utilizes **microRepair** technology, which consists of zinc-substituted carbonate-hydroxyapatite crystals that are chemically similar to natural tooth enamel. These microparticles bond to the enamel and dentin surfaces, filling micro-cracks and promoting remineralization. The 'Plus Parodontogel' formulation is specifically enriched with hyaluronic acid to support the healing and hydration of gum tissue, lactoferrin to provide antibacterial defense, and Zinc PCA to inhibit the formation of dental plaque and biofilm. In clinical research, it is being investigated as a para-probiotic-based adjunct therapy to manage periodontitis and improve glycemic control in patients with type 2 diabetes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Biorepair Plus Parodontogel.